BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7459276)

  • 1. Three pyruvate kinase variants with increased affinity for PEP.
    Elder GE; Lappin TR; Lawson BE; Bridges JM
    Br J Haematol; 1981 Mar; 47(3):371-81. PubMed ID: 7459276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pyruvate kinase variant with an increased affinity for phosphoenolpyruvate in an individual with congenital non-spherocytic haemolytic anaemia.
    Smith O; Temperley IJ; Tipton K; McCann SR
    Clin Lab Haematol; 1983; 5(3):237-41. PubMed ID: 6653061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of kinetic abnormalities of erythrocyte pyruvate kinase in congenital deficiencies].
    Boivin P; Galand C
    Pathol Biol (Paris); 1977 Mar; 25(3):161-7. PubMed ID: 323784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyruvate kinase deficiency: characterization of two new genetic variants.
    Dente L; D'Urso M; Di Maio S; Brancaccio V; Luzzatto L
    Clin Chim Acta; 1982 Dec; 126(2):143-54. PubMed ID: 7151276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythrocyte pyruvate kinase deficiency. The influence of physiologically important metabolites on the function of normal and defective enzymes.
    Lakomek M; Winkler H; Pekrun A; Krüger N; Sander M; Huppke P; Schröter W
    Enzyme Protein; 1994-1995; 48(3):149-63. PubMed ID: 8589802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congenital non-spherocytic haemolytic anaemia variants with primary and secondary pyruvate kinase deficiency. II. Enzymatic studies.
    Gumińska M; Wazewska-Czyzewska M
    Br J Haematol; 1979 Jan; 41(1):125-32. PubMed ID: 154343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical characterization of four new erythrocyte pyruvate kinase variants.
    Tegos C; Anagnostoulis G
    Acta Haematol; 1994; 92(2):91-6. PubMed ID: 7817710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human erythrocyte pyruvate kinase: characterization of the recombinant enzyme and a mutant form (R510Q) causing nonspherocytic hemolytic anemia.
    Wang C; Chiarelli LR; Bianchi P; Abraham DJ; Galizzi A; Mattevi A; Zanella A; Valentini G
    Blood; 2001 Nov; 98(10):3113-20. PubMed ID: 11698298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte pyruvate kinase deficiency: characterization of a new variant (PK "Aarau").
    Lakomek M; Winkler H; Scharnetzky M; Tillmann W; Laier G; Marti HR; Schröter W
    Blut; 1984 Mar; 48(3):123-9. PubMed ID: 6697002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies with human erythrocyte pyruvate kinase (PK): effects of modification of sulfhydryl groups.
    Valentine WN; Paglia DE
    Br J Haematol; 1983 Mar; 53(3):385-98. PubMed ID: 6824584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of erythrocyte pyruvate kinase deficiency and related metabolic disorders in patients with hematological diseases.
    Gherardi M; Bierme R; Corberand J; Vergnes H
    Clin Chim Acta; 1977 Aug; 78(3):465-71. PubMed ID: 18306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A mutant of human red cell pyruvate kinase with high affinity for phosphoenolpyruvate.
    Boivin P; Galand C
    Enzyme; 1974; 18(1):37-47. PubMed ID: 4850232
    [No Abstract]   [Full Text] [Related]  

  • 13. Hereditary erythrocyte pyruvate-kinase (PK) deficiency and chronic hemolytic anemia: clinical, genetic and molecular studies in six new Spanish patients.
    Vives-Corrons JL; Marie J; Pujades MA; Kahn A
    Hum Genet; 1980; 53(3):401-8. PubMed ID: 7372343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seven pyruvate kinase variants characterized by the ICSH recommended methods.
    Miwa S; Fujii H; Takegawa S; Nakatsuji T; Yamato K; Ishida Y; Ninomiya N
    Br J Haematol; 1980 Aug; 45(4):575-83. PubMed ID: 7426438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of pyruvate kinase from the liver of a patient with aberrant erythrocyte pyruvate kinase, PK Nagasaki.
    Nakashima K; Miwa S; Fujii H; Shinohara K; Yamauchi K; Tsuji Y; Yanai M
    J Lab Clin Med; 1977 Dec; 90(6):1012-20. PubMed ID: 925478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic properties of pyruvate kinase in human maternal leukocytes in fetal malnutrition.
    Mameesh MS; Metcoff J; Costiloe P; Crosby W
    Pediatr Res; 1976 Jun; 10(6):561-5. PubMed ID: 1272633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an erythrocyte pyruvate kinase variant in a family from Latium with non-spherocytic congenital haemolytic anaemia.
    Papa G; De Laurenzi A; Isacchi GC; Bonifazi G; Parziale L; Salvati AM
    Acta Haematol; 1979; 61(5):288-94. PubMed ID: 111457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyruvate kinase Greensboro. A four-generation study of a high K0.5s (phosphoenolpyruvate) variant.
    Valentine WN; Herring WB; Paglia DE; Steuterman MC; Brockway RA; Nakatani M
    Blood; 1988 Sep; 72(3):1054-9. PubMed ID: 3416067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biphasic reaction kinetics in an anomalous isozyme of erythrocyte pyruvate kinase.
    Paglia DE; Konrad PN; Wolff JA; Valentine WN
    Clin Chim Acta; 1976 Dec; 73(3):395-405. PubMed ID: 1000857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enzymatic pattern of glucose metabolic pathways in pyruvate kinase-deficient erythrocytes.
    Gumińska M; Wazewska-Czyzewska M
    Clin Chim Acta; 1975 Oct; 64(2):165-72. PubMed ID: 126827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.